How can genetic analysis be used to determine chronic lymphocytic leukemia (CLL) treatment?
Biosimilars: Making biological agents availble worldwide
Won Seog Kim
Precision medicine for MDS, what drugs for which patients?
TP53 mutations in CLL: a large retrospective analysis
Telomere dysfunction to predict clinical outcomes in CLL